STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS

dc.contributor.authorUrunbaeva D.A
dc.contributor.authorNajmutdinova D.K
dc.contributor.authorSadikova N.G
dc.contributor.authorGafurova D.S
dc.date.accessioned2025-12-31T15:36:45Z
dc.date.issued2023-01-11
dc.description.abstractThe aim of our study was to study the hypoglycemic and cardioprotective effect of empagliflozin in patients with type 2 diabetes mellitus cardiovascular diseases
dc.formatapplication/pdf
dc.identifier.urihttps://scholarexpress.net/index.php/wbph/article/view/1965
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/49186
dc.language.isoeng
dc.publisherScholar Express Journals
dc.relationhttps://scholarexpress.net/index.php/wbph/article/view/1965/1711
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWorld Bulletin of Public Health; Vol. 18 (2023): WBPH; 9-14
dc.source2749-3644
dc.subjecttype 2 diabetes mellitus
dc.subjectatherosclerotic cardiovascular disease
dc.subjectsodium glucose cotransporter type
dc.titleSTUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
da_2023_study_of_the_hypoglycemic_and_cardioprot.pdf
item.page.filesection.size
169.23 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections